Last reviewed · How we verify
NCT03800459
Effect of a Family Empowerment Program on Coping, Problem Solving in Parents, and Quality of Life in Children With Cystic Fibrosis
NA trial testing family empowerment program in Cystic Fibrosis in 48 participants. Completed in 2 June 2017.
26 February 2017
Quick facts
| Lead sponsor | Selcuk University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 48 |
| Start date | 14 December 2016 |
| Primary completion | 26 February 2017 |
| Estimated completion | 2 June 2017 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- family empowerment program
Conditions studied
- Cystic Fibrosis — all drugs for Cystic Fibrosis →
Sponsor
Selcuk University
Who can join
Adults 6 to 18, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parents of children with cystic fibrosis (CF) experience high levels of stress and problems. Family empowerment interventions provide important support for many patients with CF and their families. However,there is a lack of research exploring the effects of such empowerment programs on coping, and Problem Solving among parents, and Quality of Life in Children with CF. The present study aimed to assess the effect of a family empowerment program-based nursing intervention on parents coping with stress and problem solving, and quality of life children with CF.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Patient navigator programmes for children and adolescents with chronic diseases.
Lalji R, Koh L, Francis A, Khalid R, et al · · 2024 · cited 7× · PMID 39382077 · DOI 10.1002/14651858.cd014688.pub2 -
Appetite stimulants for people with cystic fibrosis.
McTavish D, Thornton J. · · 2022 · cited 4× · PMID 36149378 · DOI 10.1002/14651858.cd008190.pub3
Verify or expand the search:
- PubMed search for NCT03800459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cystic Fibrosis
Currently open trials in the same condition.
- NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
- NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
- NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
- NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
- NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting
Other Selcuk University trials
Trials by the same sponsor.
- NCT07402499 — Validation of a Virtual Reality Timed Up and Go Test in Adults With Chronic Non-Specific Low Back Pain · not yet recruiting
- NCT07364591 — Immediate Effect of Kinesiotaping With Rounded Shoulder Posture in University Students · NA · not yet recruiting
- NCT07381244 — Validity, Reliability, and Clinical Correlates of Immersive Virtual Reality Adaptation of the Five Times Sit-to-stand Te · not yet recruiting
- NCT07373704 — Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis · not yet recruiting
- NCT07362368 — Virtual Reality-Based Five-Repetition Sit-to-Stand Test in Young Adults · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03800459 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Selcuk University
- Last refreshed: 11 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03800459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing